首页|循环肿瘤DNA在结直肠癌中的应用

循环肿瘤DNA在结直肠癌中的应用

Circulating tumor DNA in colorectal cancer

扫码查看
结直肠癌是我国常见的癌症类型之一,也是世界第二大死因.随着诊断技术的发展和包括手术和化疗在内的治疗方法的进步,其预后得到了极大的改善,但是仍有一定比例的患者在接受根治性治疗后出现复发.循环肿瘤DNA(ctDNA)是来自肿瘤细胞的循环游离DNA(cfDNA)片段,是一种新型的生物标志物,可以用于监测结直肠癌患者的放化疗效果和术后复发情况.与传统的生物标志物相比,ctDNA具有更高的特异度和灵敏度,并且可以在患者的血清中稳定存在.通过检测ctDNA的水平可以对患者的病情进行更加准确的评估,并根据检测结果制定更加个性化的治疗方案.在结直肠癌的诊疗过程中,ctDNA具有较高的特异度和灵敏度,通过检测患者的血清ctDNA水平,可以较早期判断患者是否可能患有结直肠癌.同时,通过比较患者治疗前后的血清ctDNA水平变化,可以评估患者的治疗效果.在结直肠癌的随访中,ctDNA同样具有很高的特异度和灵敏度,通过检测患者的血清ctDNA水平,可以有效地判断患者的复发情况.若患者血清ctDNA水平持续升高,则表明患者可能出现了复发,需要及时进行进一步的检查和干预.总之,ctDNA是一种新型的生物标志物,具有较高的特异度和灵敏度,可以用于监测结直肠癌患者的放化疗效果和术后复发情况,目前被认为是液体活检中的新型生物标志物之一,可作为放化疗效果评估、术后复发监测等的生物标志物.本文综述了 ctDNA的特征及其在结直肠癌诊断、治疗和随访中的应用.
Colorectal cancer is a prevalent form of cancer in China and is the second leading cause of death worldwide.The prognosis of the disease has greatly improved with the development of diagnostic techniques and advances in therapeu-tic methods,including surgery and chemotherapy.However,a certain percentage of patients still experience recurrence after radical treatment circulating tumor DNA(ctDNA)is a cell-free circulating DNA(cfDNA)fragment derived from tumor cells.It is a novel biomarker that can be used to monitor the efficacy of radiotherapy and postoperative recurrence in colorectal cancer patients.Compared to traditional biomarkers,the ctDNA has higher specificity and sensitivity and can be stably present in patients'serum.Detecting ctDNA levels allows for a more accurate assessment of the patient's condition and the formulation of a personalized treatment plan based on test results.The use of ctDNA in the diagnosis and treatment of colorectal cancer offers high specificity and sensitivity.By detecting the level of ctDNA in a patient's se-rum,it is possible determined whether they may have colorectal cancer at an early stage.Meanwhile,by comparing the changes in serum ctDNA levels before and after treatment,the therapeutic effect of patients can be evaluated.In colorec-tal cancer follow-up,ctDNA has high specificity and sensitivity.By detecting the patient's serum ctDNA level,recur-rence can be effectively determined.If the serum ctDNA level of the patient continues to increase,it suggests that the pa-tient may have relapsed and requires prompt examination and intervention.In conclusion,ctDNA is a promising biomark-er with high specificity and sensitivity.It can be used to monitor the effectiveness of radiotherapy and detect postoperative recurrence in patients with colorectal cancer.It is currently considered one of the novel biomarkers in liquid biopsy.It can be used to assess radiotherapy effect and monitor postoperative recurrence.This makes it a valuable biomarker.This paper presents a review of the characteristics of ctDNA and its applications in the diagnosis,treatment and follow-up of colorectal cancer.

Colorectal cancerCirculating tumor DNAApplication

伍龙、吴欢、黄飞、李晓云、甄运寰、李海洋

展开 >

贵州医科大学附属医院肛肠外科,贵州贵阳 550004

贵州医科大学附属医院感染科

贵州医科大学附属医院肝胆外科

结直肠癌 循环肿瘤DNA 应用

国家自然科学基金地区科学基金贵州省卫生健康委科学技术基金

82060440gzwkj2023-042

2024

中华全科医学
中华预防医学会,安徽省全科医学会

中华全科医学

CSTPCD
影响因子:1.688
ISSN:1674-4152
年,卷(期):2024.22(3)
  • 44